Answers are grounded in this paper and cite their sources.
Background Hypophosphatemia is a clinically important complication of nutritional rehabilitation in patients with anorexia nervosa (AN). Refeeding‐related hypophosphatemia is often suspected initially. However, persistent hypophosphatemia despite phosphate supplementation or an atypical biochemical pattern should prompt evaluation for alternative causes. Intravenous iron is a recognized cause of fibroblast growth factor 23 (FGF23)‐mediated hypophosphatemia. However, longitudinal documentation of intact FGF23 and renal phosphate handling before and after intravenous iron exposure during nutritional rehabilitation for severe AN remains limited. Case Presentation A 17‐year‐old female with restricting‐type AN and severe malnutrition (body mass index, 13.2 kg/m 2 ) was admitted for nutritional rehabilitation. She had severe iron‐deficiency anemia and received intravenous saccharated ferric oxide. Hypophosphatemia developed despite prophylactic phosphate supplementation and persisted despite escalation of oral supplementation and the addition of intravenous phosphate replacement. Refeeding‐related hypophosphatemia was initially suspected. However, the percentage tubular reabsorption of phosphate (%TRP) and tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR) were markedly reduced during hypophosphatemia, indicating inappropriate renal phosphate wasting. Serial measurements demonstrated a transition from a normal pre‐exposure intact FGF23 concentration (36.4 pg/mL) to marked FGF23 excess (782–838 pg/mL), followed by a progressive decline after iron withdrawal. Serum phosphate gradually recovered. No symptoms or organ dysfunction attributable to hypophosphatemia occurred. Conclusion Hypophosphatemia during nutritional rehabilitation in AN should not automatically be attributed to refeeding‐related mechanisms. Persistent hypophosphatemia despite supplementation, particularly when accompanied by renal phosphate wasting, should prompt reassessment of the underlying mechanism and evaluation for FGF23‐mediated hypophosphatemia in patients exposed to intravenous iron.
No takes yet. Share an insight, caveat, or question.
Nishiue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: